Data governance framework for the implementation of automated healthcare-associated infection surveillance using large language models: Privacy-by-design with open-source de-identification pipeline

✅ Just Accepted
🔗 bit.ly/3UuP4Qm

Performance of the recent Duke criteria versions in patients with suspected infective endocarditis and sufficient cardiac imaging: The more things change, the more they remain the same

✅ Just Accepted
bit.ly/47VJZUb

On IDSA’s & @HIVMA’s Science Speaks blog: Learn more postnatal CMV infection in preterm infants, how rates of IPD since the COVID-19 pandemic shape vaccine recommendations and other research in @JIDJournal ready to inform clinical practice. bit.ly/4BBski2

Mixed Models, Not Mixed Messaging: Reply to Haddad, et al.

✅ Just Accepted
🔗 bit.ly/4e9oJ0L

Managing HIV in Primary Care with Project ECHO: Highlighting a Successful Delivery Model

✅ Just Accepted
🔗 bit.ly/4BBZf6h

CID extends another round of congratulations to our 2025 Reviewers of the Year! 🎉 First announced in Feb. 2026, the awardees are:

-Nicolás Cortés-Penfield, MD, FACP, FIDSA
-Esteban Martinez, MD, PhD
-Jose F. Portugal Gonzales, MD

Learn more: bit.ly/4aoKJ6S

Cefepime–Zidebactam for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria, Including Metallo-β-Lactamase Producers: A Phase 2, Open-Label, Single-Arm, Multicenter Study

✅ Just Accepted
⭐ Editor's Choice
🔗 bit.ly/47KCJKQ

On IDSA’s & @HIVMA’s Science Speaks blog: Check out insights from the editors of a new, ongoing series of articles in @CIDJournal highlighting how experienced clinicians deploy problem-solving skills to navigate complex cases. bit.ly/48mkxr0

Availability of IV Artesunate for Severe Malaria

✅ Just Accepted
🔗 bit.ly/4kmyzQE

In Reply: Clarifying the Analysis Population and Sensitivity Analyses in the SUPLA Trial

✅ Just Accepted
🔗 bit.ly/4yMrIDE

Post-randomization exclusions and estimand clarity in a trial of direct long-acting cabotegravir/rilpivirine initiation

✅ Just Accepted
🔗 bit.ly/4eS3alx

Geographic Differences Among Tetanus Cases—United States, 2009–2023

✅ Just Accepted
🔗 bit.ly/4zSY4h3

Interpreting Albumin-Carbapenem Effect Modification: Functional Form, Time Zero, and Local Overlap

✅ Just Accepted
🔗 bit.ly/3U3AbV0

Not All Extrapulmonary Tuberculosis Is Equal: Site-Specific Mortality in a National Indian Cohort

✅ Just Accepted
bit.ly/4z8Msqh

Association Between Neighbourhood-level Antibiotic Utilization and the Rate of Community-Associated C. difficile (CA-CDI) Infection: An Ecological Study

✅ Just Accepted
🔗 bit.ly/4yI1fqX

What Follows an Antibiotic Is Not Necessarily Caused by It

✅ Just Accepted
🔗 bit.ly/4exqmWb

Ertapenem in Hypoalbuminemia: Methodological and Pharmacokinetic Considerations

✅ Just Accepted
🔗 bit.ly/4zQVjNh

Hypoalbuminemia and Pharmacokinetics: Revisiting Fundamental Principles and Clinical Perspectives

✅ Just Accepted
🔗 bit.ly/47BCXUx

Empirical Antifungal Treatment of Critically Ill Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Bayesian Perspective

✅ Just Accepted
bit.ly/4kcLjcx

Antibiotic Stewardship, Resistance, and Mortality in Vancomycin-Resistant Enterococcus: A Quasi-Experimental Study of Linezolid Restrictions

✅ Just Accepted
⭐ Editor's Choice
🔗 bit.ly/4BcHhqZ